A detailed history of Silver Oak Securities, Inc transactions in Amgen Inc stock. As of the latest transaction made, Silver Oak Securities, Inc holds 1,423 shares of AMGN stock, worth $373,153. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,423
Previous 1,633 12.86%
Holding current value
$373,153
Previous $510,000 10.2%
% of portfolio
0.05%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$309.38 - $337.38 $64,969 - $70,849
-210 Reduced 12.86%
1,423 $458,000
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $95,641 - $116,228
364 Added 28.68%
1,633 $510,000
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $26,080 - $31,482
-97 Reduced 7.1%
1,269 $360,000
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $47,815 - $53,942
187 Added 15.86%
1,366 $393,000
Q3 2023

Nov 20, 2023

SELL
$218.65 - $271.46 $774,458 - $961,511
-3,542 Reduced 75.03%
1,179 $316,000
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $716,304 - $847,015
3,343 Added 242.6%
4,721 $1.05 Million
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $16,708 - $20,364
74 Added 5.67%
1,378 $333,000
Q4 2022

Feb 02, 2023

SELL
$229.03 - $291.01 $12,596 - $16,005
-55 Reduced 4.05%
1,304 $342,000
Q3 2022

Oct 23, 2023

SELL
$224.46 - $253.15 $795,037 - $896,657
-3,542 Reduced 75.03%
1,179 $265,000
Q3 2022

Oct 20, 2022

SELL
$224.46 - $253.15 $50,952 - $57,465
-227 Reduced 14.31%
1,359 $306,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $97,590 - $108,601
423 Added 36.37%
1,586 $393,000
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $255,011 - $282,108
1,163 New
1,163 $294,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Silver Oak Securities, Inc Portfolio

Follow Silver Oak Securities, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Silver Oak Securities, Inc with notifications on news.